Cours CytRx Corporation Nasdaq
Actions
US2328286081
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 644 k 586 k |
---|---|---|---|---|---|
Résultat net 2022 | -4 M -3,64 M | Résultat net 2023 | - 0 | VE / CA 2022 | - |
Trésorerie nette 2022 | 1,15 M 1,04 M | Trésorerie nette 2023 | 2,04 M 1,86 M | VE / CA 2023 | - |
PER 2022 |
-1,05
x | PER 2023 |
1,91
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 99,44% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Stephen Snowdy
CEO | Chief Executive Officer | 55 | 10/01/22 |
John Caloz
DFI | Director of Finance/CFO | 72 | 01/10/07 |
Cristina Newman
SEC | Corporate Secretary | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jennifer Simpson
CHM | Chairman | 55 | 29/07/21 |
Cary Claiborne
BRD | Director/Board Member | 64 | 27/07/22 |
Joel Caldwell
BRD | Director/Board Member | 69 | 12/07/17 |
Varia. 1 janv. | Capi. | |
---|---|---|
+1,77% | 42,75 Md | |
+47,70% | 41,61 Md | |
+12,24% | 41,34 Md | |
-8,83% | 26,59 Md | |
+7,44% | 25,49 Md | |
-23,01% | 18,12 Md | |
+30,56% | 12,24 Md | |
-1,82% | 11,76 Md | |
+8,35% | 11 Md |